Verastem Oncology
VSTM
#8150
Rank
ยฃ0.13 B
Marketcap
ยฃ3.12
Share price
3.69%
Change (1 day)
-37.64%
Change (1 year)

Revenue for Verastem Oncology (VSTM)

Revenue in 2024 (TTM): ยฃ7.9 Million

According to Verastem Oncology 's latest financial reports the company's current revenue (TTM ) is ยฃ7.94 Million. In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of ยฃ2.14 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Verastem Oncology from 2011 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ7.9 M
2023 N/A-100%
2022 ยฃ2.14 M41.09%
2021 ยฃ1.52 M-97.66%
2020 ยฃ64.93 M387.85%
2019 ยฃ13.31 M-36.76%
2018 ยฃ21.04 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ8.07 M 1.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ44.19 B 556,320.00%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ10.09 B 127,028.00%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ31.97 B 402,427.07%๐Ÿ‡ฌ๐Ÿ‡ง UK